Dr. Wu Skincare Co., Ltd. (TPEX: 6523)

Dr. Wu Skincare Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	478.94	474.88	651.55	1,029	712.36	627.03
Short-Term Investments	691.42	781.47	696.8	366.3	871.2	977.98
Trading Asset Securities	19.54	18.66	17.77	19.65	20.71	23.32
Cash & Short-Term Investments	1,190	1,275	1,366	1,415	1,604	1,628
Cash Growth	-15.50%	-6.67%	-3.43%	-11.82%	-1.48%	10.27%
Accounts Receivable	185.97	138.92	130.52	149.05	102.34	182.48
Other Receivables	10.37	2.8	1.84	2.06	306.62	6.71
Receivables	196.34	141.71	132.36	151.11	408.97	189.19
Inventory	208.39	188.76	115.2	115.18	103.02	102.23
Prepaid Expenses	9.15	16.43	3.84	7.84	8.44	7.51
Other Current Assets	3.04	2.78	2.04	2.13	0.3	2.9
Total Current Assets	1,607	1,625	1,620	1,691	2,125	1,930
Property, Plant & Equipment	30.44	7.65	14.54	22.51	28.82	39.07
Long-Term Investments	266.26	119.7	134.74	93.33	77.48	48.41
Other Intangible Assets	0.64	0.79	0.05	0.25	2.91	4.74
Long-Term Accounts Receivable	-	-	1.99	6.68	11.25	-
Long-Term Deferred Tax Assets	8.6	7.77	6.71	10.07	8.76	4.74
Other Long-Term Assets	23.09	4.83	5.63	7.33	10.74	25.42
Total Assets	1,936	1,765	1,783	1,831	2,265	2,053
Accounts Payable	52.16	62.69	46.71	89.95	28.52	42.22
Accrued Expenses	-	90.73	80.1	95.23	51	48.13
Current Portion of Leases	9.73	5.05	10.08	9.83	9.39	9.15
Current Income Taxes Payable	29.77	80.35	40.51	40.15	121.39	2.32
Current Unearned Revenue	13.72	8.26	8.05	13.59	12.44	8.81
Other Current Liabilities	248.39	41.8	33.75	30.42	17.56	22.68
Total Current Liabilities	353.77	288.88	219.18	279.16	240.3	133.3
Long-Term Leases	39.44	-	5.6	15.68	24.59	33.98
Long-Term Deferred Tax Liabilities	1.73	0.98	28.18	-	-	0
Other Long-Term Liabilities	1.26	1.26	1.26	1.26	1.49	1.49
Total Liabilities	396.2	291.12	254.22	296.1	266.37	168.77
Common Stock	450.48	450.48	450.48	450.48	450.48	450.48
Additional Paid-In Capital	331.89	331.89	421.99	512.08	692.27	1,143
Retained Earnings	757.29	691.96	548.78	479.09	778.38	291.15
Comprehensive Income & Other	-	-	107.77	93.31	77.45	-0.61
Total Common Equity	1,540	1,474	1,529	1,535	1,999	1,884
Shareholders' Equity	1,540	1,474	1,529	1,535	1,999	1,884
Total Liabilities & Equity	1,936	1,765	1,783	1,831	2,265	2,053
Total Debt	49.17	5.05	15.68	25.5	33.98	43.13
Net Cash (Debt)	1,141	1,270	1,350	1,389	1,570	1,585
Net Cash Growth	-18.56%	-5.96%	-2.78%	-11.54%	-0.94%	7.35%
Net Cash Per Share	25.29	28.17	29.95	30.80	34.76	35.17
Filing Date Shares Outstanding	45.03	45.05	45.05	45.05	45.05	45.05
Total Common Shares Outstanding	45.03	45.05	45.05	45.05	45.05	45.05
Working Capital	1,253	1,336	1,400	1,412	1,885	1,797
Book Value Per Share	34.19	32.73	33.94	34.07	44.37	41.82
Tangible Book Value	1,539	1,474	1,529	1,535	1,996	1,879
Tangible Book Value Per Share	34.18	32.71	33.94	34.07	44.30	41.71
Machinery	-	-	-	-	1	1.27
Leasehold Improvements	-	-	-	-	20.64	34.82

Source: S&P Capital IQ. Standard template. Financial Sources.